Plerixafor
- Product NDC
- 25021-416
- 11-digit product format
- 250210416
- Labeler code
- 25021
- Product ID
- 25021-416_69c3fb68-4dfb-43db-bc59-421e4b3dfa0c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Plerixafor
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- Sagent Pharmaceuticals
- Application
- ANDA206644
- Marketing category
- ANDA
- Marketing start
- 2024-08-01
- Substance
- PLERIXAFOR
- Active strength
- 20 mg/mL
- Pharmacologic classes
- Hematopoietic Stem Cell Mobilizer [EPC], Increased Hematopoietic Stem Cell Mobilization [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Plerixafor
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PLERIXAFOR | 20 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | S915P5499N |
| Rxcui | 828700 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 25021-416-01 | Plerixafor | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | | 1 |
| 25021-416-01 | Plerixafor | 1.2 mL in 1 VIAL | INJECTION, SOLUTION | 1.2 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 25021-416 | PLERIXAFOR INJECTION, SOLUTION [SAGENT PHARMACEUTICALS] | 1 | Current NDC, 2 package rows | 20240805_711b7bf7-4385-4365-b12a-ede6c3f1ed45.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 25021-416-01 | 25021041601 | 1 VIAL in 1 CARTON (25021-416-01) / 1.2 mL in 1 VIAL | 1 vial | 2024-08-01 | No | No | Historical |